The March market started with a scene of despair and a declining market.
Entering March, I thought the mood would feel fresh... but when the lid was lifted, it started in a market with more declining stocks than last month.
The Pharmaceutical Sector has been rising for about a week because of rumors like 'a new virus from Wuhan...'.
Personally, I'm fed up with this.
Are they going to create another disease and sell ridiculous drugs again...?
How will Robert Kennedy Jr respond?
Considering the sloppiness of the Corona Vaccine, there are doubts whether this will become a long-term trend.
Originally, the Pharmaceutical Sector often declines due to 'side effects' issues, and in terms of annual trends, it is not a very strong sector in the long term.
Nevertheless, personally, I think ABBV is a good stock.
In addition, beverage-related sectors (especially coffee and Beer) and Tobacco (MO and PM) also seem to be doing well.
As for whether this trend will continue in the long term, honestly, I do not know.
Knowing that price movements over a week or a month can be quickly reversed, trusting the current 'flow' seems dangerous.
Still, it is a strange 'down market.'
It is completely different from last year.
It feels, how should I put it, that the 'smell' is different.
I felt a sense of discomfort, so I changed the screening method.
Then, in military and defense stocks such as Aerospace, brands that have never been seen before have emerged.
fujikenner
:
I think that sectors like healthcare and beverages are simply refuge for high-tech stocks and are performing well as Domestic Defensive Shares. Classic companies like Eli Lilly and Co and Coca-Cola are looking good! Although I don't own any.
sirius2xanadu
OPfujikenner
:
That's right. It is also a defensive stock for domestic demand. However, it can be quite unremarkable in the long term. Also, regarding Eli Lilly, there are reports that the obesity treatment drug works well for diabetic patients, but causes side effects for others, and that should soon come to the surface. I think HIMS shouldn't have gotten involved with the generic version of that drug.
fujikenner : I think that sectors like healthcare and beverages are simply refuge for high-tech stocks and are performing well as Domestic Defensive Shares. Classic companies like Eli Lilly and Co and Coca-Cola are looking good! Although I don't own any.![Smile [Smile]](https://emoticon.moomoo.com/small_emoticon/v2_240316/80px/000m.png?imageMogr2/thumbnail/36x36)
sirius2xanadu OP fujikenner : That's right. It is also a defensive stock for domestic demand.
However, it can be quite unremarkable in the long term.
Also, regarding Eli Lilly, there are reports that the obesity treatment drug works well for diabetic patients, but causes side effects for others, and that should soon come to the surface.
I think HIMS shouldn't have gotten involved with the generic version of that drug.